Clinical Trials on Metabolic Dysfunction-associated Fatty Liver Disease in United Kingdom
Total 1229 results
-
Elif OralCompletedFatty Liver | Hypertriglyceridemia | NASH - Nonalcoholic Steatohepatitis | Familial Partial LipodystrophyUnited States
-
Conatus Pharmaceuticals Inc.CompletedNon-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
University of FloridaTerminatedGestational Diabetes Mellitus in PregnancyUnited States
-
Georgetown UniversityCompletedNonalcoholic SteatohepatitisUnited States
-
Mayo ClinicUniversity of Florida; Orphan MedicalCompleted
-
Massachusetts General HospitalRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Meridian Bioscience, Inc.Bristol-Myers SquibbCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Navidea BiopharmaceuticalsCompletedNonalcoholic Steatohepatitis | NASH - Nonalcoholic SteatohepatitisUnited States
-
Milton S. Hershey Medical CenterRecruitingExercise | NASH - Nonalcoholic Steatohepatitis | NASH | LiverUnited States
-
University of IowaRecruiting
-
Eli Lilly and CompanyCompletedNonalcoholic SteatohepatitisUnited States, Spain, Japan, United Kingdom, Belgium, France, Italy, Israel, Mexico, Poland
-
University of California, San DiegoDaiichi Sankyo, Inc.CompletedNonalcoholic SteatohepatitisUnited States
-
Milton S. Hershey Medical CenterNoom Inc.CompletedNon-alcoholic SteatohepatitisUnited States
-
University of VirginiaNational Center for Complementary and Integrative Health (NCCIH)CompletedFatty Liver | Non-alcoholic SteatohepatitisUnited States
-
Merck Sharp & Dohme LLCRecruitingHepatic Impairment | Non-alcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCovanceCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Jeffrey L Zitsman, MDCompletedObstructive Sleep Apnea Syndrome | Metabolic Syndrome | Insulin Resistance | Morbid Obesity | Nonalcoholic Fatty Liver DiseaseUnited States
-
University of North Carolina, Chapel HillNational Institute of General Medical Sciences (NIGMS)CompletedNon-alcoholic SteatohepatitisUnited States
-
Medical College of WisconsinWithdrawnNon-Alcoholic SteatohepatitisUnited States
-
National Human Genome Research Institute (NHGRI)TerminatedLiver Cirrhosis | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steato-HepatitisUnited States
-
Madaus IncUniversity of Pennsylvania; Beth Israel Deaconess Medical Center; University... and other collaboratorsCompletedNon-alcoholic SteatohepatitisUnited States
-
Metacrine, Inc.Completed
-
The University of Texas Health Science Center at...National Institutes of Health (NIH); Takeda Pharmaceuticals North America,...CompletedNonalcoholic SteatohepatitisUnited States
-
Northwell HealthTerminatedNon-Alcoholic Fatty Liver Disease | Probiotics MeSH Descriptor Data 2018 | Interleukin-17 MeSH Descriptor Data 2018United States
-
Second GenomeTerminatedNonalcoholic SteatohepatitisUnited States
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingNon Alcoholic SteatohepatitisUnited States
-
AlbireoCompleted
-
Rockefeller UniversityCornell UniversityCompletedObesity | Fatty Liver | Insulin ResistanceUnited States
-
University of California, San DiegoKineMedRecruitingNon-alcoholic Fatty Liver DiseaseUnited States
-
University of WashingtonVA Puget Sound Health Care SystemCompleted
-
GenfitTerminatedNon Alcoholic SteatohepatitisUnited States
-
Bristol-Myers SquibbCompletedNon-Alcoholic SteatohepatitisUnited States
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Germany, Argentina
-
University of PittsburghCompletedSteatohepatitis, Nonalcoholic | Alcoholic Liver Disease | Non-Alcoholic Fatty Liver Disease | SteatohepatitisUnited States
-
AstraZenecaTerminatedNonalcoholic SteatohapatitisUnited States
-
EccogeneRecruiting
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
Fibronostics USA, IncCompletedNon-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Liver Inflammation | Liver Fibroses | Liver SteatosesUnited States
-
Rivus Pharmaceuticals, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Rivus Pharmaceuticals, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Manal AbdelmalekCompletedNonalcoholic SteatohepatitisUnited States
-
University of Southern CaliforniaChildren's Hospital Los AngelesCompleted
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD)United States, Japan
-
Gilead SciencesNovo Nordisk A/SCompletedNonalcoholic SteatohepatitisUnited States
-
CytoDyn, Inc.Amarex Clinical ResearchCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNonalcoholic SteatohepatitisUnited States
-
Mirum Pharmaceuticals, Inc.TerminatedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, Canada, Puerto Rico